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ABSTRACT
The phenomenal commercial success of many nutraceutical products, dietary and health
supplements indicate increasing levels of consumer acceptance to the usage of health supplements in
Malaysia. As much as these products are consumed for health purposes, lack of effective control by
drug authority leaves much to be desired. Legal issues such as marketing approval, product liability,
safety, advertising, trade description (nutrition labelling & health claims) would undoubtedly emerge
as direct implications from widespread sales and consumption of such products. Consumers' health
and safety are at risk where nutraceuticals can easily penetrate into the market without any need of
undergoing clinical studies, as opposed to pharmaceuticals. This article was written based on
research that has identified several causal factors to the above-mentioned issues. First, nutraceuticals
are loosely classified as in between food and drugs. Due to the loose classification scheme,
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manufacturers tend to opt that their products be classified as food to escape strict clinical
evaluations. This leads to the issue of misleading health claims made on its labels and advertisements.
The article examines regulation of nutraceuticals in Malaysia and identifies significant issues therein.
Comparative analysis with Japanese nutraceutical regulations was made to learn how Japanese
classifies its nutraceuticals under specific categories known as ‘Food for Specified Health Uses
(FOSHU)’. Products bearing the FOSHU logo went through strict clinical tests and are allowed to make
health claims on their labels – and were proven effective and safe for consumption as claimed. The
article made several recommendations for the establishment of a legal framework to regulate
nutraceutical products in Malaysia.
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ABSTRACT 
The phenomenal commercial success of many nutraceutical products, 
dietary and health supplements indicate increasing levels of consumer 
acceptance to the usage of health supplements in Malaysia. As much as 
these products are consumed for health purposes, lack of effective 
control by drug authority leaves much to be desired. Legal issues such 
as marketing approval, product liability, safety, advertising, trade 
description (nutrition labelling & health claims) would undoubtedly 
emerge as direct implications from widespread sales and consumption of 
such products. Consumers' health and safety are at risk where 
nutraceuticals can easily penetrate into the market without any need of 
undergoing clinical studies, as opposed to pharmaceuticals. This article 
was written based on research that has identified several causal factors 
to the above-mentioned issues. First, nutraceuticals are loosely classified 
as in between food and drugs. Due to the loose classification scheme, 
manufacturers tend to opt that their products be classified as food to 
escape strict clinical evaluations. This leads to the issue of misleading 
health claims made on its labels and advertisements. The article 
examines the regulation of nutraceuticals in Malaysia and identifies 
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significant issues therein. Comparative analysis with Japanese 
nutraceutical regulations was made to learn how Japanese classifies its 
nutraceuticals under specific categories known as ‘Food for Specified 
Health Uses (FOSHU)’. Products bearing the FOSHU logo went through 
strict clinical tests and are allowed to make health claims on their labels 
– and were proven effective and safe for consumption as claimed. The 
article made several recommendations for the establishment of a legal 
framework to regulate nutraceutical products in Malaysia.  
Keywords: nutraceutical, drugs, regulation, safety, FOSHU. 
 
MENINGKATKAN PENGAWAL SELIAAN PRODUK 




Kejayaan komersial produk nutraseutikal, pemakanan dan makanan 
kesihatan menunjukkan peningkatan tahap penerimaan pengguna 
terhadap penggunaan suplemen kesihatan di Malaysia. Walaupun 
produk-produk ini digunakan untuk tujuan kesihatan, kekurangan 
kawalan yang berkesan oleh pihak berkuasa banyak menimbulkan 
persoalan. Isu-isu undang-undang seperti kelulusan pemasaran, liabiliti 
produk, keselamatan, pengiklanan, keterangan perdagangan (label 
pemakanan & tuntutan kesihatan) pasti akan muncul sebagai implikasi 
langsung dari penjualan dan pengambilan produk yang meluas. 
Kesihatan dan keselamatan pengguna berisiko di mana nutraseutikal 
dapat menembusi pasaran dengan mudah tanpa perlu melalui kajian 
klinikal, berbanding farmaseutikal. Article ini ditulis berdasarkan kajian 
yang telah dikenal pasti beberapa faktor penyebab kepada isu-isu yang 
dinyatakan di atas. Pertama, pengklasifikasian nutraseutikal sebagai di 
antara kategori makanan dan dadah yang longgar. Oleh kerana skim 
pengkelasan yang longgar, pengeluar cenderung memilih bahawa 
produk mereka dikelaskan sebagai makanan untuk melepaskan penilaian 
klinikal yang ketat. Ini membawa kepada isu mengenai tuntutan 
kesihatan yang mengelirukan yang dibuat pada label dan iklannya. 
Makalah ini mengkaji peraturan nutraseutikal di Malaysia dan mengenal 
pasti isu-isu penting di dalamnya. Analisis perbandingan dengan 
peraturan nutraseutikal Jepun dibuat untuk mengetahui bagaimana Jepun 
mengklasifikasikan nutraseutikal terutamanya di bawah kategori tertentu 
yang dikenali sebagai ‘Food for Specified Health Uses (FOSHU)’. 
Produk yang mengandungi logo FOSHU melalui ujian klinikal yang 
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ketat dan dibenarkan untuk membuat tuntutan kesihatan pada label 
mereka - dan terbukti berkesan dan selamat untuk digunakan seperti 
yang didakwa. Artikel ini membuat beberapa saranan untuk penubuhan 
rangka kerja undang-undang untuk mengawal selia produk nutraseutikal 
di Malaysia. 
Kata Kunci: nutraseutikal, dadah, peraturan, keselamatan, FOSHU. 
 
INTRODUCTION 
There has been a growing trend amongst Malaysian consumers to opt 
for nutraceutical products. This due to the increasing awareness of 
health issues that are closely linked with dietary intake and eating 
lifestyle. The growing demand for nutraceutical products is mainly 
attributed to its proclaimed benefit to maintain health and wellbeing. 
The rapid rise of healthcare cost is also another driving factor which 
prompts consumers to opt for the concept of preserving good health 
from food, in alternative to prescribed drugs and modern medicines. It 
is found that the escalating popularity of nutraceutical products are 
very obvious specifically for the population from the middle- and the 
high-income group as they are becoming more health-conscious. These 
parts of the population have resorted to food supplements, nutraceutical, 
and herbal products to maintain a healthy lifestyle. Undoubtedly, 
nutraceutical products contribute to a substantial portion of the 
Malaysian health care sector affecting the public at large. 
 Globally, the natural healthcare industry is growing rapidly, 
which opens up huge opportunities and vast potential for those 
nutraceutical industry players. In terms of global statistics, the rapid 
growth of the nutraceutical market in the United Statesy, for instance, 
is estimated to increase steadily at a Compound Annual Growth Rate 
of 5.5%. The figure, as reported by the United States Transparency 
Market Research, was projected to reach US$102.6 billion by 2024, 
from US$64.8 billion in 2016.1 In Malaysia, based on an analysis by 
Technavio's research analyst, the health supplement market is projected 
to grow at a Compound Annual Growth Rate (CAGR) of 7% annually. 
 
1  Transparency Market Research, “Market Research Report,” Transparency 
Market Research, 2015, 
https://www.transparencymarketresearch.com/us-nutraceuticals-
market.html. 
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The local market is mainly dominated by the vitamins and dietary 
supplements, with an impressive market share of approximately 49% 
in 2014. The trend was estimated to grow until the end of 2019. The 
analyst has attributed such a figure to the factor of raising awareness 
among the consumers on the importance of food supplements. 
 
DEFINITIONS OF ‘NUTRACEUTICAL 
Nutraceutical, is a relatively new terminology which is apparently a 
combination of ‘nutrition’ and ‘pharmaceutical’. It essentially denotes 
“food or food product that reportedly provides health and medical 
benefits, including the prevention and treatment of disease”. 2 
Interestingly, the concept of nutraceutical emerges due to the evolution 
and link between ‘nutrition’ and ‘health’. This so-called nutraceutical 
revolution is said to be the driving force for the food industry to become 
a research-oriented sector, which is similar if not equivalent to the 
pharmaceutical industry. 3  Despite various definitions of the term 
nutraceutical, the gist lies on an important element of food or related 
ingredients to provide its consumers with the benefit of increased 
health and wellbeing, more than what is offered by conventional food 
products with general nutrition.4 There are some other words that are 
related to the concept of nutraceutical. ‘Functional food’ and ‘dietary 
supplements’ for instance, are sometimes used interchangeably to 
denote similar meaning with nutraceutical in various jurisdictions, but 
some authors argue that those terminologies carry slightly different 
meanings. Since different jurisdictions have their own terminologies to 
regulate nutraceutical or equivalent products, it is interesting to note 
that Japan has been using the term ‘functional foods’ since the mid-
1980s to regulate “processed foods containing ingredients that worked 
in the health and the physiological effects on the human body like the 
 
2  K. P. Sampath Kumar Debjit Bhowmik, Harish Gopinath, B. Pragati 
Kumar, S. Duraivel, “Nutraceutical-A Bright Scope and Opportunity of 
Indian Health Market,” The Pharma Innovation 1, no. 11 (2013): 29–41. 
3  M. Prasad Palthur, S. Sajala Palthur, and Suresh Kumar Chitta, 
“Nutraceuticals: A Conceptual Definition,” International Journal of 
Pharmacy and Pharmaceutical Sciences 2, no. 3 (2010): 19–27. 
4  A Fatimah, “Functional Foods from the Dietetic Perspective,” Jurnal 
Kesihatan Masyarakat Isu Khas (2002): 8–13, 
http://journalarticle.ukm.my/4410/. 
Enhancing Regulation of Nutraceutical Products in Malaysia  355 
 
 
nervous system, immune system and the body’s defence outside the 
function of nutrients”.5 
 In the European Union, there is no specific regulation dealing 
with nutraceutical but the EU Directive 2002/46/EC 3 referred to the 
term ‘food supplements’ and ‘novel foods’ instead. A “food supplement” 
is defined in Directive 2002/46/EC 3 as:  
 
“Foodstuffs the purpose of which is to supplement the normal diet and 
that are concentrated sources of nutrients or other substances with a 
nutritional or physiological effect, alone or in combination, marketed 
in dose form, namely forms such as capsules, pastilles, tablets, pills and 
other similar forms, sachets of powder, ampoules of liquids, drop 
dispensing bottles, and other similar forms of liquids and powders 
designed to be taken in measured small unit quantities”.  
 
“Novel foods” are defined in Regulation (EC) No 258/976 as foods and 
food ingredients that have not been used for human consumption to a 
significant degree within the Community before 15 May 1997 and 
which fall under various categories. 
 In another jurisdiction such as Canada, there is no specific 
legislation governing nutraceutical as it falls either in the category of 
food or drugs. A product may be considered as drugs if it satisfies the 
definition of drugs. A ‘drug’ is defined in the Food and Drugs Act 1985 
as: 
“Any substance or mixture of substances manufactured, sold or 
represented for use in (a) the diagnosis, treatment, mitigation or 
prevention of a disease, disorder, abnormal physical state, or the 
symptoms thereof, in man or animal, (b) restoring, correcting or 
modifying organic functions in man or animal or, (c) disinfection in 
premises in which food is manufactured, prepared or kept”.  
 
If a product meets the said criteria, it will be regulated as a subset of 
drugs under the Natural Health Products Regulations. On the other 
hand, Food and Drugs Act 1985 defines “food” as “any article 
 
5  Toshio Shimizu, “Health Claims on Functional Foods: The Japanese 
Regulations and an International Comparison,” Nutrition Research 
Reviews, 2003, https://doi.org/10.1079/NRR200363. 
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manufactured, sold or represented for use as food or drink by man, 
chewing gum, and any ingredient that may be mixed with food for any 
purpose whatever.” Although there exists no specific legislation on 
nutraceutical, an attempt to define the term has been made by the 
Nutritional Sciences Bureau of the Food Directorate of Health Canada. 
According to the Bureau, nutraceutical is “a product isolated or purified 
from foods that is generally sold in medicinal forms not usually 
associated with food. A nutraceutical is demonstrated to have a 
physiological benefit or provide protection against chronic disease”.6 
 In the United States, nutraceuticals are known as dietary 
supplements.7 It is a product that contains nutrients derived from food 
products that are concentrated in liquid, capsule, tablets, soft gels, gel 
caps, or powder form. Section 3 of the Dietary Supplement Health and 
Education Act (DSHEA) 1994 provides dietary supplement a product 
that contains dietary ingredients such as vitamins, minerals, herbs or 
other botanicals and amino acids that are intended to supplement the 
diet. Such a product needs no approval from the United States Food 
and Drug Administration (FDA) before it can be marketed. As this 
product claims to provide health benefits, the Commission on Dietary 
Supplement Labels, established under Section 12(c) of DSHEA 1994, 
holds the duty to evaluate how best to provide truthful, scientifically 
valid, and not misleading information to consumers. This is to help 
such consumers to make informed and appropriate health care choices 
for themselves and their families. 
 Meanwhile, in India, the Food Safety and Standard Act 2006 
had created a special third category for ‘Food for Dietary 
Uses/Functional Foods/Nutraceutical/Health Supplements’ in addition 
to the first two categories namely conventional food and drugs. This is 
to allow those products to have specific regulatory requirements. 8 
Since the term nutraceutical is broad and lacks uniform definitions, it 
is a need for the term to be defined with precision for regulatory 
purposes. A clear definition is needed as in certain jurisdictions, it is 
unclear whether such a product should remain as either food or drugs. 
 
6  Md Faruque Ahmad et al., “Nutraceutical Market and Its Regulation,” 
American Journal of Food Technology, 2011, 
https://doi.org/10.3923/ajft.2011.342.347. 
7  Debjit Bhowmik, Harish Gopinath, B. Pragati Kumar, S. Duraivel, 
“Nutraceutical-A Bright Scope and Opportunity of Indian Health Market.” 
8 Palthur, Palthur, and Chitta, “Nutraceuticals: A Conceptual Definition.” 
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It is also important to regulate nutraceuticals without unduly 
compromising consumer rights to take greater responsibility for their 
own good health. 
 
REGULATION ON NUTRACEUTICAL PRODUCTS IN 
MALAYSIA 
The Ministry of Health Malaysia is vested with the authority to regulate 
and implement relevant laws on the regulation of food and 
pharmaceutical products in Malaysia. When it comes to classifying 
whether a product belongs to the food or drug category, two 
departments under the Ministry came into the spotlight, as stated in 
Table 1, namely: National Pharmaceutical Regulatory Agency (NPRA) 
and Food Safety & Quality Division (FSQD).9 
Table 1: Guide to Classification of Food-Drug Interface Products 
Product/Ingredients 
Pure form of 
active ingredient 
(singly or in 
combination) 
Natural products that 
are not traditionally 





• Amino acid 








• Royal jelly 
• Noni juice 
• Pegaga tablet 
• Herbal product 
• Rooibose tea 
• Tongkat ali (powder 
or sachet) 
• Manja harum 
• Less than 80% food 
ingredients or more than 
20% active ingredients of 
natural products with 
pharmacological/theraputic 
properties, singly or in 
combination. But if the 
latter possess high 
potencies, the product shall 
be reviewed by the 
Committee, even if they 
contain less than 20% of 
these ingredients 
• 80% or more food 
ingredients (singly or in 
combination) 
 
9  Focus group discussion between authors and officers of NPRA held on 
10th October 2017. 






Source: National Pharmaceutical Control Bureau, Ministry of Health, 
Malaysia.10 
 
National Pharmaceutical Regulatory Agency (NPRA) 
NPRA is responsible for regulating nutraceutical products that fall 
under the category of drugs. Regulation 7 of the Control of Drugs and 
Cosmetics Regulation 1984 expressly “prohibits manufacture, sell, 
support, import, possess or administer of any product unless the 
product is a registered product and that person holds the appropriate 
licence required and issued by the Drug Control Authority (DCA)”. 
The DCA is an executive body established under the Control of Drugs 
and Cosmetics Regulations 1984 entrusted to ensure the safety, quality, 
and efficacy of pharmaceuticals, health, and personal care products that 
are marketed in Malaysia. In its Term of Reference, the DCA is given 
the authority to: -  
 
• “review matters related to product registration;  
• consider recommendations proposed by the secretariat and register 
any product subject to such conditions as it may impose, reject any 
application for the registration of any product, grant exemptions, 
issue such certification required by any country importing such a 
product, suspend or cancel registration of any product, make 
decisions related to regulatory policies; 
• maintain a register of the products registered; and 
• impose requirements for registration of products”.11  
 
10  The data in the table is the summary of a compilation by the food-drug 
interphase (FDI) committee 
https://www.npra.gov.my/images/Announcement/2015/NRC-2015-
day2/TMHS04-P-SuSiewChing03-08-2013.pdf. 
11  Drug Control Authority, “Terms of Reference,” Ministry of Health 
Malaysia, 2019, 
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Safety and quality of a product under the category of drug is assured 
by strict registration procedures, supervision, and enforcement. The 
enactment of such mandatory procedures is meant to minimise the risks 
of having defective drugs on the market. At the same time, it accords 
protection towards consumers from fraudulent or misleading product 
information so long as the product is classified as drugs. It is to be noted 
that the DCA does not have jurisdiction to deal with food products, but 
is mainly in charge of drugs. Neither does it have jurisdiction over 
products that are classified as ‘in between food or drugs’. In relation to 
nutraceuticals, they are not directly or automatically categorised as 
pharmaceutical drugs and do not fall under the purview of the DCA. 
As some nutraceuticals may fall in between the two, the Ministry of 
Health Malaysia has published the Guide to Classification of Food-
Drug Interface Products to act as a classification scheme effective from 
9th July 2014 (herein ‘The Guideline’) as a guideline for product 
classification.12   
 On the other hand, if the product in question is found to contain 
“less than 80% of food-based ingredients and more than 20% of the 
active ingredients”, it will be classified as a drug. NPRA would be the 
authority responsible for drug registration, monitoring, and 
enforcement. Despite the above methods of classification, there may 
exist some other products with specific ingredients, such as those 
containing high potencies yet with less than 20% of active ingredients. 
In this regard, these products will be reviewed by a panel of committees 
appointed by the Ministry of Health Malaysia which has the authority 
to decide its classification. The same practice is also observed in the 
event of uncertainties on the issue of efficacy and safety of these 
products. Manufacturers of pharmaceutical drugs need to adhere to 
registration procedures that embrace safety requirements imposed by 
the DCA, as well as compliance with Good Manufacturing Practice 
(GMP). The DCA is responsible to perform clinical tests or require 




12  National Pharmaceutical Regulatory Agency, “Guide to Classification of 
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issues are always the paramount concern and the government via the 
DCA and the NPRA are monitoring the matters seriously in ensuring 
safe consumption of nutraceuticals. 
Food Safety & Quality Division (FSQD) 
Under the Guideline, a product is classified as food if it contains “80% 
or more of food ingredients, either single or in combination, and with 
equal to or less than 20% of biologically active ingredients of natural 
products with pharmacological and/or therapeutic properties”.13  All 
food products are directly regulated and monitored by FSQD under the 
auspices of the Food Act 1983. Section 17 of the Food Act 1983 and 
Regulation 18 of the Food Regulations 1985 require food products to 
be safe for consumption and prohibit the acts of false labelling and 
deceiving advertisement.  
 The absence of a specific definition for nutraceuticals in 
Malaysia (as mentioned above) leads to the issue of categorisation of 
products that cannot be automated. Since there are two separate 
agencies empowered to control and regulate nutraceutical products in 
Malaysia, it gives rise to different standards and procedures applicable 
to industry players. As the NPRA and the FSQD specify their own 
standard procedures to be adhered to, it opens up possibilities of the 
same product to be treated differently depending on which agency is 
governing it. 
 Based on the focus group discussion held with the FSQD, 
several noteworthy issues were discovered particularly in relation to 
the regulation of nutraceuticals.14 In terms of function, the FSQD is 
responsible for the planning, implementation, monitoring, and 
evaluation of the Food Safety and Quality Programme that is 
implemented at national, state and district levels, entry points, and local 
authorities. The main objective is to protect the public against health 
hazards and fraud in the preparation, sale and consumption of food and 
facilitating trade. The FSQD receives mandate as food regulator from 
the Food Act 1983 and its regulations.  
 
13  National Pharmaceutical Regulatory Division, Ministry of Health 
Malaysia, Drug Registration Guidance Document (DRGD), (2016) 
revised (2019): 53-62. 
14  Focus group discussion between authors and officers of FSQD held on 
11th April 2017. 
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 Officers from the FSQD were of the view that the Food Act 
1983 is a piece of legislation that regulates food manufacturing 
industries on a self-regulation basis. Their view and observation are 
based on their experience in handling cases related to food safety. Their 
main responsibility is to ensure that the safety of food remains with 
manufacturers. The FSQD does not hold any responsibility to ensure 
food safety in any part of the food manufacturing processes. The 
guidelines and regulations contained in the Food Act 1983 and its 
regulation are applicable to food manufacturers whereby they are 
responsible to ensure all stages of the production and distribution of 
food satisfies the prescribed legal requirements - in particular, health 
protection, protection against fraud, and hygienic handling of food. 
Food manufacturers must examine and make available for examination 
the food/goods according to the good manufacturing procedures. The 
Food Act 1983 and its regulations provide a long list of guidelines for 
food manufacturers to ensure safety and quality compliance. 
 The Food Act 1983 is a self-regulatory legal instrument that 
the industry should be familiarised with. However, the FSQD claimed 
that awareness about the existence of the Food Act 1983 amongst 
manufacturers is still very much desired 15 . As a result, food 
manufacturers were found to be neglectful of the quality and safety 
requirements in the Food Act 1983 and its regulations. The FSQD has 
been putting effort into educating the industry by organising seminars 
or hands-on training to increase the level of awareness amongst 
industry members. Also, due to the non-compulsory nature of these 
training, the low level of participation from industry members is 
alarming.16 The FSQD was also vested with regulatory authority to 
police the Food Act 1983 and Food Regulations. Since food is not a 
category that is treated as exclusively as drugs, the enforcement 
mechanism remains a crucial problem for the department due to small 




15  Focus group discussion between authors and officers of FSQD held on 
11th April 2017. 
16  Neither data nor statistic was provided by the FSQD, but this general 
information was revealed during the focus group discussion. 
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Efficacy and safety issues 
In Malaysia, it is a common practice by local manufacturers of 
nutraceutical products to register and label them as food supplements. 
Obviously, registration requirements for food supplements are not as 
stringent as those imposed on pharmaceutical products and hence, this 
explains why many nutraceuticals are registered under the former 
rather than the latter categories. Consequently, it is not a legal 
obligation to comply with the above-mentioned safety requirement – 
hence skipping the strict monitoring procedures applicable to drugs. It 
is not a requirement to perform clinical testing or lab test to ensure the 
safety, efficacy, and credibility of the product. Food supplements can 
be made available for purchase freely in the open market.  
 On the other hand, once the nutraceutical products are 
classified as pharmaceutical drugs, they may only be sold to consumers 
over the counter at registered pharmacies and some may also require 
prescriptions before they could pass hand to consumers. As far as food 
products are concerned, they are regarded as non-registrable products 
because they are presumed to be safe based on the fact that it is possible 
to extrapolate from a known history of exposure to them. In contrast to 
drugs, they have no such widespread exposure history, and hence it is 
not possible to maintain such a presumption. In short, food products 
can reach the market without any registration requirements since 
evaluation is not necessary before it is marketed. This means that the 
safety standard of the said product is ambiguous and can only be 
inspected upon complaints received from consumers. 
 
Misleading health claims and advertisements 
Section 16 of the Food Act 1983 prohibits the acts of false labelling 
which includes “false, misleading or deceptive as regards its character, 
nature, value, substance, quality, composition, merit or safety, strength, 
purity, weight, origin, age or proportion” that contravenes the purpose 
or objectives of Food Act 1983. On the other hand, Section 17 of the 
Food Act 1983 clearly forbids false or misleading health claims on 
advertisements. To supplement these two provisions, Regulation 18(6) 
of the Food Regulations further provides that one is not allowed to 
make any claims that are not justifiable or substantiated.  
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Other kinds of prohibitions mentioned in Regulation 18(6) includes:  
 
• “claims stating that any particular food will provide an adequate 
source of all essential nutrient; 
• claims implying that a balanced diet or a combination of a variety of 
foods cannot supply adequate amounts of all nutrients;  
• claims suggesting that food can prevent, alleviate, treat or cure a 
disease, disorder or other physiological function;  
• claims that cause the consumer to doubt the safety of similar food; 
and claims that arouse or exploit fear in the consumer.”  
 
Nevertheless, there is a lack of evidence to suggest that the FSQD has 
been able to effectively monitor the manufacturer’s compliance with 
the above regulations. In one case involving a nutraceutical-millionaire 
company, D’Herbs were found guilty under Section 17 of the Foods 
Act 1983 for promoting misleading advertisements of his two 
nutraceutical products. 17  The company also confessed that 
nutraceutical products sold which “could improve blood circulation” 
and “improve immunisation system” were not true and was not 
substantiated with any clinical evidence. Hence, it infers that all 
promises made in the advertisements were false hope to consumers – 
which may be detrimental to their health after consuming the products 
for a long period of time.18 However, the same advertisement was also 
published on their website and such health claims were not removed, 
hence exposing online consumers to further safety risks. 
 On the other hand, manufacturers of nutraceuticals in Malaysia 
(including some ASEAN countries) have relied heavily on testimony-
 
17  Bernama, "D'Herbs company fined RM11,000 for misleading 
advertisements," The Sun Daily, 2017, 
https://www.thesundaily.my/archive/2170152-HTARCH429147. 
18  Mahyuddin Daud et al., “‘Unsafe’ Nutraceuticals Products on the Internet: 
The Need for Stricter Regulation in Malaysia,” in The 5th International 
Conference on Information Technology for Cyber and IT Service 
Management 2017 (Indonesia: IEEExplorer, 2017); BERNAMA, “Iklan 
Bertentangan Akta Makanan, Syarikat D’Herbs Didenda RM11,000,” 
Astro Awani, 2017, http://www.astroawani.com/berita-malaysia/iklan-
bertentangan-akta-makanan-syarikat-dherbs-didenda-rm11-000-133179. 
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based marketing strategy with a lack of credible scientific evidence.19 
Generally, the evidence on the efficacy of local nutraceuticals are 
limited and scanty and prompts safety issues and the adverse impact of 
the consumption of those products. Due to the booming of social media, 
nutraceutical manufacturers have taken such opportunities to market 
their products online with heavy reliance on unsubstantiated 
testimonies. This research also discovered that some manufacturers 
even went as far as making therapeutic health claims that are dubious 
and remain unsubstantiated, such as healing cancer, heart problems, 
high blood pressures, and the likes.20 Although consumers can lodge a 
report to the Malaysian Communications and Multimedia Commission 
(MCMC) for publishing false information online under the purview of 
Section 211 and 233 of the Communications and Multimedia Act 1998, 
the action of taking down of misleading online advertisements may 
serve as temporary measures to stop its dissemination. Some may not 
even take down misleading online advertisement if there are no 
complaints received on the matter. 
 Based on the above analysis, it was found that the present legal 
framework regulating nutraceuticals requires improvement to address 
the above issues. The authors now turn to examine the legal framework 
applicable in Japan to learn the best practices and useful experiences 
that may be adopted in Malaysia. 
 
REGULATION OF NUTRACEUTICALS IN JAPAN 
The proliferation of consumption of nutraceuticals has prompted 
regulatory efforts at the global stage due to increased awareness of their 
potential health and safety risks towards consumers. In its own terms, 
Japan refers to nutraceuticals as a health food, which is systematically 
regulated. Before analysis of the categories of health food in Japan is 
made, it is significant to understand briefly that all consumer-related 
laws and regulations are supervised by the Consumer Affairs Agency 
 
19  Helmi Haja Mydin, “The Dangers of ‘Natural’ Remedies,” New Straits 
Times, 2015, https://www.nst.com.my/news/2015/09/dangers-‘natural’-
remedies. 
20  Daud et al., “‘Unsafe’ Nutraceuticals Products on the Internet: The Need 
for Stricter Regulation in Malaysia.” 
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(CAA) established on 1st September 2009. 21  The CAA is an 
independent government agency that reports directly to the Prime 
Minister of Japan. The CAA acts as the central agency and regulator 
that leads and becomes the driving force on consumer-related 
administrative services, which includes regulatory and monitoring 
roles similar to the FSQD under the Ministry of Health Malaysia. The 
CAA grants approval to products that intend to bear specific health 
claims after adhering to necessary requirements to ensure efficacy and 
market regulation. On the other hand, the Ministry of Health, Labour, 
and Welfare regulates medicines where strict regulations are in place, 
similar to the DCA. There are three types of functional foods that are 
authorised to bear function claim:  
 
1. Foods for Specified Health Uses (FOSHU);  
2. Foods with Nutrient Function Claims (FNFC) and;  
3. Foods with Function Claims.22 
 
The system or scheme, which started in 1991, is specifically known as 
Foods for Specified Health Use (FOSHU), under the authority of the 
CAA. FOSHU symbolises; 
 
 “food containing ingredients with functions for health and officially 
approved to claim its physiological effects on the human body.  It is 
intended to be consumed for the maintenance or promotion of health or 
special health uses by people who wish to control health conditions, 
including blood pressure or blood cholesterol”.23  
 
Before any FOSHU product can be legally allowed to enter the market, 
the CAA is mandated to perform rigorous assessment via the 
submission of experimental data and other documents to ensure that the 
product is equally effective and safe for consumption. This means that 
 
21  Consumer Affairs Agency Japan, “Towards a Safe and Prosperous Life 
with Consumers’ Peace of Mind,” 2018, 
https://www.caa.go.jp/en/about_us/booklet/pdf/00booklet_en.pdf. 
22  Consumer Affairs Agency Japan, 22. 
23  Ministry of Health Labour and Welfare Japan, “Food for Specified Health 
Uses (FOSHU),” Ministry of Health Labour and Welfare Japan, 2019, 
https://www.mhlw.go.jp/english/topics/foodsafety/fhc/02.html. 
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any health claim made by the manufacturer or producer of the product 
must obtain approval from the CAA.24 The paramount consideration is 
to ensure that consumers are able to make wise decisions and be well 
informed before they decide to purchase a FOSHU product. However, 
such approval is not obligatory if manufacturers do not wish to label 
their products as FOSHU. 
 In terms of laws and regulations, FOSHU products are heavily 
regulated in the sense that rigorous assessment and evaluation of the 
safety and effectiveness of proposed specified health uses is a 
mandatory requirement as imposed by the government. The specific 
requirements for FOSHU approval as imposed by the CAA are;  
 
i. Effectiveness on the human body is clearly proven;  
ii. Absence of any safety issues (animal toxicity tests, confirmation 
of effects in the cases of excess intake, etc.);  
iii. Use of nutritionally appropriate ingredients (e.g. no excessive use 
of salt, etc.); 
iv. Guarantee of compatibility with product specifications by the time 
of consumption;  
v. Established quality control methods, such as specifications of 
products and ingredients, processes, and methods of analysis. 
 
 
Figure 1: Seal for FOSHU Approval 
Source: The Ministry of Health, Labour and Welfare, Japan 
 
24  Focus group discussion between authors and Dr. Tsuyoshi Chiba, Head of 
Department of Food Function and Labelling, National Institute of Health 
and Nutrition Japan on 5th December 2018. 
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As far as FOSHU categories are concerned, for the purpose of FOSHU 
approval, other than the ‘regular’ FOSHU, there are three categories, 
namely; qualified FOSHU, standardised FOSHU, and reduction of 
disease risk FOSHU. Qualified FOSHU embraces “food with a health 
function which is not substantiated on scientific evidence that meets 
the level of FOSHU, or the food with certain effectiveness but without 
an established mechanism of the effective element for the function”.  
 Meanwhile, standardized FOSHU is meant for, “foods with 
sufficient FOSHU approvals and accumulation of scientific evidence”, 
while reduction of disease risk FOSHU, “is permitted when the 
reduction of disease risk is clinically and nutritionally established in an 
ingredient”. 25  The processes for obtaining FOSHU approval is 
summarised in the following chart: 
 
Figure 2: Flow Chart of FOSHU Approval 
Source: The Ministry of Health, Labour and Welfare, Japan.26 
 
One of the significant features of the FOSHU system is that it requires 
the manufacturers to ensure clear and correct labelling to prevent any 
 
25 Ministry of Health Labour and Welfare Japan, “Food for Specified Health 
Uses (FOSHU).” 
26  https://www.mhlw.go.jp/english/topics/foodsafety/fhc/02.html 
368               IIUM LAW JOURNAL VOL. 28 (S1) 2020 
 
 
misleading information to the consumers. Therefore, before FOSHU 
approval can be granted, the manufacturer must;  
“tabulate both published available publications and internal reports on 
the effectiveness of the product and/or its ingredients and provide a 
summary of each available publication or report. The tabulation must 
include in vitro metabolic and biochemical studies, in vivo studies, and 
randomized controlled trials on Japanese people”.27  
 
It is quite interesting to note that despite the rigorous clinical process 
that FOSHU products have to go through, manufacturers managed to 
sell them for as cheap as 140 yen per product and still make a profit. 
FOSHU products can easily be found in local stores, in the form of 
daily food products such as green tea. 
 The second category of health food in Japan is Foods with 
Nutrient Function Claims (FNFC). It is used to: 
 
“complement “the daily requirement of nutrients (vitamins, minerals, 
etc.) which tend to be insufficient in everyday diet. Given that the food 
product contains certain amounts of nutrients whose function has 
already been substantiated by scientific evidence, it can bear a nutrient 
function claim prescribed by the Standards without submitting a 
notification to the government”.28  
 
It is worth noting that there was a regulatory shift in the health food 
system when the government decided to introduce ‘Foods with 
Function Claims’ (FFC) in 2015. 29  The FFC aims to permit 
manufacturers to make claims for the function based on their own 
evidence embracing both safety, and effectiveness. This means that 
instead of clinical trials which is a requirement under FOSHU, the new 
the FFC allows systematic literature reviews as scientific evidence to 
prove the claim of the related health benefits. Product liability remains 
 
27  Kazuhiko Yamada et al., “Health Claim Evidence Requirements in 
Japan,”The Journal of Nutrition 138, no. 6 (2008), 
https://academic.oup.com/jn/article/138/6/1192S/4670290. 
28  Consumer Affairs Agency Japan, “Towards a Safe and Prosperous Life 
with Consumers’ Peace of Mind.” 
29  Consumer Affairs Agency Japan. 
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with the business owner or manufacturer – a similar position to the 
FSQD in Malaysia. Manufacturers who wish to have the FFC labels on 
their products may submit information relating to food safety, 
effectiveness and relevant information on adverse health effects to the 
Secretary-General of the CCA – based on scientific evidence. However, 
unlike FOSHU, the CCA shall not evaluate the safety and effectiveness 
of the said product. Products bearing the FFC labels are allowed to 
claim specified functions that can be achieved, such as “helpful for 
maintaining and promoting health”, “helps maintain good GI condition” 
or “slows fat absorption”. It is to be noted that food products that are 
labelled as a nutritional supplement, health supplement, or nutrient 
controlling food are considered as ‘foods in general’ and hence are not 
allowed to label any function claim. The FFC is also seen as an 
alternative to FOSHU – a lesser level for classification of food with 
health claims, in case the product does not qualify in a stricter FOSHU 
group.30 The role of the National Institute of Health and Nutrition Japan 
is to provide information on the safety and efficacy of health foods to 
consumers. Consumers may lodge complaints directly to the CAA for 
any issues over healthy foods.  
 
ENHANCING CURRENT REGULATION – LESSON FROM 
THE JAPANESE FOSHU SYSTEM 
It is observed that the strength of the functional food systems in Japan 
lies in the mandatory requirement of scientific clinical trials or 
evidence. Essentially, the FOSHU system gives paramount importance 
to the maintenance of health via the prevention of lifestyle-related 
diseases based on the consumption of nutraceuticals supported with 
scientific evidence.31 Based on the preceding discussion, it is observed 
that there is a need to enhance the current legal mechanism to regulate 
nutraceuticals in Malaysia. Some of the challenges which have been 
identified include the absence of a specific definition for the term 
nutraceuticals, which leads to another problem of the absence of 
 
30  Focus group discussion between authors and Dr. Tsuyoshi Chiba, Head of 
Department of Food Function and Labelling, National Institute of Health 
and Nutrition Japan on 5th December 2018. 
31 Ishi Khosla, “Diet Diary: Functional Foods and Japanese FOSHU — 
Foods For Specified Health Us,” The Indian Express, 2018, 
https://indianexpress.com/article/lifestyle/health/diet-diary-functional-
foods-and-japanese-foshu-5154423/. 
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standalone classification for nutraceuticals or food supplements. It is 
therefore proposed that Malaysia should adopt a new classification for 
categories of nutraceutical or alternatively to introduce the concept of 
functional foods with three specific categories under FOSHU (Foods 
for Specified Health Uses, Foods with Nutrient Function Claims and 
Foods with Function Claims). These functional foods should be placed 
under the authority of FSQD, so that food products which fit into these 
three categories can be better regulated. 
 Another issue relates to irresponsible marketing strategies 
involving unsubstantiated testimonials and misleading claims due to a 
lack of, or inadequate research and controlled clinical trials.32 With the 
increasing number of nutraceutical products in the local market, 
consumers are posed with increasing risk of harm if their safety, quality 
and efficacy remain unchecked or unregulated. Indeed, intense and 
reliable research is inevitable to ascertain whether existing 
nutraceutical products in the market are really safe and efficient as 
inappropriate use of these products would put the consumers’ health at 
risk and eventually leads to adverse impacts. Health claims on foods 
should always be substantiated scientifically. As the current regulatory 
system suffers from a lack of quality control to regulate nutraceutical 
products which fall under the category of food or food supplements, in 
comparison to the strict procedures imposed on pharmaceutical drugs, 
it is proposed that nutraceuticals undergo more rigorous safety 
evaluation. Thus, it is inappropriate to classify them as food, but as a 
standalone category, similar to the FOSHU classification in Japan. 
There is also a need for nutraceutical products to undergo clinical or 
lab tests before they can be marketed to ensure that efficient clinical 
data of its health and medical benefits are obtained to enable consumers 
to make a well-informed decision before consuming the products. 
 Despite strict and heavy regulation, pharmaceutical drugs may 
still be found harmful to consumers. It is therefore not surprising that 
such harmful effects are produced by the food supplements that are not 
required to undergo various tests and procedures. For instance, the 
NPRA has been receiving reports of cases involving adverse reactions 
to alternative medicines from time to time. This includes the  
“contamination or substitution with herbs known to be toxic (such as 
Magnolia, Aristolochia, Chapparal), contamination with heavy metals 
 
32  Daud et al., “‘Unsafe’ Nutraceuticals Products on the Internet: The Need 
for Stricter Regulation in Malaysia.” 
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as well as the illegal inclusion of a drug (for example, corticosteroids, 
analgesics, hypoglycemic agents)”33. Emulating a systematic FOSHU 
scheme in particular, where the requirement of clinical evidence of 
efficacy or expert evidence would be an avenue to overcome the 
problem of unsubstantiated testimonials and misleading claims. 
Undeniably, it would be time-consuming and would implicate 
additional cost on the part of nutraceutical manufacturers but 
consumers’ safety remains as a primary concern.  
 
CONCLUSION 
Enhancing the current legal framework and mechanism is inevitable 
through imposing rigorous safety requirements and strict adherence to 
acceptable standards of safety and quality on nutraceutical products. 
Adopting some important features of the FOSHU system which has 
been successfully practiced in Japan would be necessary to close the 
gap in current regulation on nutraceuticals in Malaysia. After all, the 
ultimate aim of moving towards a stricter regulation scheme is mainly 
to prevent unwanted adverse impacts on consumers as well as to 
facilitate the sustenance of human health with greater certainty, 
substantiated with scientific evidence.  
 The FOSHU system in Japan may be considered as a model 
where nutraceutical products that bear the FOSHU mark have gone 
through preclinical tests and are therefore evidenced-based. One of the 
significant features of the FOSHU system is that it requires the 
manufacturers to ensure clear and correct labelling to prevent any 
misleading information to consumers. Therefore, before FOSHU 
approval can be granted, the manufacturer must “tabulate both 
published available publications and internal reports on the 
effectiveness of the product and/or its ingredients and provide a 
summary of each available publication or report. The tabulation must 
include in vitro metabolic and biochemical studies, in vivo studies, and 
randomized controlled trials on Japanese people.  
 
33  National Pharmaceutical Regulatory Agency, “Senarai Produk Dikesan 
Mengandungi Bahan Terlarang Yang Diterima Melalui Pelaporan Kesan 
Sampingan Ubat,” National Pharmaceutical Regulatory Agency, 2017, 
http://npra.moh.gov.my/index.php/recent-updates/adulterated-products-
unregistered. 
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 Other than FOSHU products, another category is known as 
‘Foods with Function Claims’ (FFC). The FFC aims to permit 
manufacturers to make claims for the function based on their own 
evidence embracing both safety and effectiveness. This means that 
instead of clinical trials which is a requirement under the FOSHU 
system, the new FFC allows systematic literature reviews as scientific 
evidence to prove the claim of the related health benefits. Product 
liability remains with the business owner or manufacturer – a similar 
position to the FSQD in Malaysia. Manufacturers who wish to have the 
FFC labels on their products may submit information relating to food 
safety, effectiveness and relevant information on adverse health effects.  
 Essentially, the strength of the functional food system in Japan 
lies in the mandatory requirement of scientific clinical trials or 
evidence, a feature of which should be emulated by Malaysia to 
improve the existing legislation. In a nutshell, it is proposed to 
strengthen the existing regulatory structure and process by enforcing 
stringent safety criteria and strict adherence to the appropriate 
protection and quality standards on nutraceutical products. To close the 
gap in current nutraceuticals regulation in Malaysia, it would be 
appropriate to adopt some important features of the FOSHU system 
which has been successfully practised in Japan. In spite of everything, 
the ultimate objective of moving towards a heavier regulatory scheme 
is primarily to avoid harmful adverse effects and to promote the 
protection of human health with greater confidence, based on scientific 
proof. 
 
 
 
 
